Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia
Authors
Keywords
Antimicrobial resistance, Ceftobiprole, Hospital-acquired pneumonia, Health-care-associated pneumonia, Monotherapy, MRSA, Multidrug resistance, <em class=EmphasisTypeItalic >Staphylococcus aureus</em>, Tedizolid, Telavancin
Journal
ADVANCES IN THERAPY
Volume 33, Issue 2, Pages 151-166
Publisher
Springer Nature
Online
2016-02-09
DOI
10.1007/s12325-016-0293-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Telavancin Hospital-Acquired Pneumonia Trials: Impact of Gram-Negative Infections and Inadequate Gram-Negative Coverage on Clinical Efficacy and All-Cause Mortality
- (2015) Melinda K. Lacy et al. CLINICAL INFECTIOUS DISEASES
- Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond
- (2015) Natasha Holmes et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival
- (2014) G. Ralph Corey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftobiprole Activity against over 60,000 Clinical Bacterial Pathogens Isolated in Europe, Turkey, and Israel from 2005 to 2010
- (2014) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study
- (2014) Martin E Stryjewski et al. BMC INFECTIOUS DISEASES
- A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
- (2014) S. S. Awad et al. CLINICAL INFECTIOUS DISEASES
- European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid
- (2014) J. Chastre et al. CLINICAL MICROBIOLOGY AND INFECTION
- Ceftobiprole Medocaril: A Review of Its Use in Patients with Hospital- or Community-Acquired Pneumonia
- (2014) Yahiya Y. Syed DRUGS
- Risk factors for hospital-acquired pneumonia outside the intensive care unit: A case-control study
- (2013) Nieves Sopena et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Risk Factors for Drug-Resistant Pathogens in Community-acquired and Healthcare-associated Pneumonia
- (2013) Yuichiro Shindo et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study
- (2013) Andrew A Quartin et al. BMC INFECTIOUS DISEASES
- Healthcare-Associated Pneumonia Does Not Accurately Identify Potentially Resistant Pathogens: A Systematic Review and Meta-Analysis
- (2013) James D. Chalmers et al. CLINICAL INFECTIOUS DISEASES
- Tedizolid for the Management of Human Infections: In Vitro Characteristics
- (2013) Jeffrey B. Locke et al. CLINICAL INFECTIOUS DISEASES
- Hospital-acquired pneumonia and ventilator-associated pneumonia
- (2013) François Barbier et al. CURRENT OPINION IN PULMONARY MEDICINE
- Healthcare-associated pneumonia: A US disease or relevant to the Asia Pacific, too?
- (2013) Claudia C. Dobler et al. RESPIROLOGY
- Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy
- (2013) Michael Wilke et al. Infection and Drug Resistance
- Worldwide Appraisal and Update (2010) of Telavancin Activity Tested against a Collection of Gram-Positive Clinical Pathogens from Five Continents
- (2012) Rodrigo E. Mendes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
- (2012) R. G. Wunderink et al. CLINICAL INFECTIOUS DISEASES
- Incidence of Nephrotoxicity and Association With Vancomycin Use in Intensive Care Unit Patients With Pneumonia: Retrospective Analysis of the IMPACT-HAP Database
- (2012) Ennie L. Cano et al. CLINICAL THERAPEUTICS
- Is healthcare-associated pneumonia a distinct entity needing specific therapy?
- (2012) Santiago Ewig et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Economic Impact of Ventilator-Associated Pneumonia in a Large Matched Cohort
- (2012) Marin H. Kollef et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation
- (2012) Susan C. Nicholson et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital
- (2011) Ji Ye Jung et al. BMC INFECTIOUS DISEASES
- Epidemiology, Antibiotic Therapy, and Clinical Outcomes in Health Care-Associated Pneumonia: A UK Cohort Study
- (2011) J. D. Chalmers et al. CLINICAL INFECTIOUS DISEASES
- Guidelines for the management of adult lower respiratory tract infections - Full version
- (2011) M. Woodhead et al. CLINICAL MICROBIOLOGY AND INFECTION
- Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization
- (2011) C. Garcia-Vidal et al. CLINICAL MICROBIOLOGY AND INFECTION
- Microbial Etiologies of Hospital‐Acquired Bacterial Pneumonia and Ventilator‐Associated Bacterial Pneumonia
- (2010) Ronald N. Jones CLINICAL INFECTIOUS DISEASES
- Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
- (2010) E. Rubinstein et al. CLINICAL INFECTIOUS DISEASES
- Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units
- (2010) Despoina Koulenti et al. CRITICAL CARE MEDICINE
- Risk factors and prognosis of post-operative pneumonia due to Pseudomonas aeruginosa following cardiac surgery
- (2010) N. Allou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06
- (2010) H. A. Anger et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Rethinking the concepts of community-acquired and health-care-associated pneumonia
- (2010) Santiago Ewig et al. LANCET INFECTIOUS DISEASES
- Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries
- (2008) Rajesh Chawla AMERICAN JOURNAL OF INFECTION CONTROL
- Ventilator-Associated Pneumonia
- (2008) Loreto Vidaur et al. CHEST
- Health-Care-Associated Pneumonia Among Hospitalized Patients in a Japanese Community Hospital
- (2008) Yuichiro Shindo et al. CHEST
- Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms
- (2008) Martin E. Stryjewski et al. CLINICAL INFECTIOUS DISEASES
- Appropriate vs. inappropriate antimicrobial therapy
- (2008) P.G. Davey et al. CLINICAL MICROBIOLOGY AND INFECTION
- Defining, treating and preventing hospital acquired pneumonia: European perspective
- (2008) Antoni Torres et al. INTENSIVE CARE MEDICINE
- Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy
- (2008) R. G. Masterton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started